Can a personalized exercise program boost recovery in cancer survivors?

NCT ID NCT07765927

Recruiting now Symptom relief Sponsor: Jess S. Gorzelitz Source: ClinicalTrials.gov ↗

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This pilot trial tests whether a supervised exercise program is safe, helpful, and practical for adults who have had breast or gynecologic cancer. Participants will take part in a 12-week program combining strength and aerobic training under trained guidance. The study focuses on whether people can stick with the program and complete it, along with their satisfaction and any perceived burden. It aims to gather the groundwork for a larger study on exercise as part of cancer recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Supervised, personalized exercise program combining resistance and aerobic training
What this could lead to: If successful, this could pave the way for a standard, supervised exercise program to help cancer survivors improve fitness and well-being during recovery.
What could go wrong: This is a small pilot study focused on feasibility, not effectiveness. It may not show clear health benefits, and results may not apply to all cancer survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm female reproductive organ cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER GYNECOLOGIC CANCER

Contacts and locations

Locations

University of Iowa Health Care
RECRUITING

Iowa City, Iowa, 52242, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.